Calamos Wealth Management LLC Takes Position in Teladoc Health, Inc. $TDOC

Calamos Wealth Management LLC purchased a new stake in Teladoc Health, Inc. (NYSE:TDOC) in the 1st quarter, HoldingsChannel reports. The institutional investor purchased 51,729 shares of the health services provider’s stock, valued at approximately $282,000.

A number of other large investors have also added to or reduced their stakes in TDOC. Principal Financial Group Inc. raised its holdings in Teladoc Health by 22.2% in the 1st quarter. Principal Financial Group Inc. now owns 718,712 shares of the health services provider’s stock valued at $3,917,000 after acquiring an additional 130,637 shares in the last quarter. Hsbc Holdings PLC grew its holdings in shares of Teladoc Health by 34.6% during the 1st quarter. Hsbc Holdings PLC now owns 30,956 shares of the health services provider’s stock worth $162,000 after purchasing an additional 7,956 shares in the last quarter. Abel Hall LLC bought a new position in shares of Teladoc Health in the first quarter worth $79,000. Formidable Asset Management LLC bought a new position in shares of Teladoc Health in the first quarter worth $120,000. Finally, Pictet Asset Management Holding SA raised its stake in Teladoc Health by 26.9% in the first quarter. Pictet Asset Management Holding SA now owns 33,439 shares of the health services provider’s stock valued at $182,000 after purchasing an additional 7,093 shares in the last quarter. Institutional investors and hedge funds own 76.82% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts recently weighed in on the stock. Barclays cut their price objective on shares of Teladoc Health from $8.50 to $7.00 and set an “equal weight” rating for the company in a research report on Thursday, March 26th. Bank of America raised their target price on shares of Teladoc Health from $9.00 to $10.50 and gave the company a “buy” rating in a report on Tuesday, July 7th. Citigroup boosted their target price on shares of Teladoc Health from $6.00 to $7.00 and gave the company a “neutral” rating in a research report on Tuesday, May 5th. Finally, Weiss Ratings raised shares of Teladoc Health from a “sell (e+)” rating to a “sell (d-)” rating in a report on Friday, May 22nd. Five research analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $7.67.

Insider Activity at Teladoc Health

In related news, insider Adam C. Vandervoort sold 7,906 shares of Teladoc Health stock in a transaction that occurred on Tuesday, June 2nd. The shares were sold at an average price of $7.63, for a total transaction of $60,322.78. Following the sale, the insider directly owned 110,261 shares of the company’s stock, valued at approximately $841,291.43. The trade was a 6.69% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Fernando M. Rodrigues sold 5,677 shares of the company’s stock in a transaction that occurred on Tuesday, June 2nd. The stock was sold at an average price of $7.63, for a total transaction of $43,315.51. Following the transaction, the insider owned 9,572 shares of the company’s stock, valued at approximately $73,034.36. This represents a 37.23% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold a total of 39,195 shares of company stock worth $299,058 over the last three months. 0.70% of the stock is owned by insiders.

Teladoc Health Price Performance

Teladoc Health stock opened at $9.74 on Thursday. The company has a debt-to-equity ratio of 0.75, a quick ratio of 2.72 and a current ratio of 2.80. Teladoc Health, Inc. has a 52 week low of $4.40 and a 52 week high of $9.85. The stock has a market capitalization of $1.76 billion, a P/E ratio of -10.05 and a beta of 2.10. The stock has a fifty day moving average of $7.71 and a 200-day moving average of $6.41.

Teladoc Health (NYSE:TDOC) last released its quarterly earnings data on Wednesday, April 29th. The health services provider reported ($0.36) earnings per share for the quarter, missing the consensus estimate of ($0.35) by ($0.01). Teladoc Health had a negative net margin of 6.81% and a negative return on equity of 11.45%. The business had revenue of $613.85 million during the quarter, compared to analyst estimates of $611.04 million. During the same period last year, the business earned ($0.53) earnings per share. The business’s quarterly revenue was down 2.5% compared to the same quarter last year. Teladoc Health has set its FY 2026 guidance at -1.050–0.750 EPS and its Q2 2026 guidance at -0.300–0.200 EPS. On average, sell-side analysts expect that Teladoc Health, Inc. will post -0.92 earnings per share for the current fiscal year.

Teladoc Health Company Profile

Teladoc Health, Inc is a leading global provider of virtual healthcare services, offering on-demand medical consultations via phone, video, and mobile app platforms. The company connects patients with licensed physicians and specialists for non-emergency medical issues, mental health support, dermatology, and chronic condition management. By leveraging digital technologies and data analytics, Teladoc aims to enhance accessibility, reduce healthcare costs, and improve patient outcomes through personalized care plans and remote monitoring.

Teladoc’s service portfolio includes general medical visits, behavioral health sessions, expert medical services for complex cases, and wellness programs designed to support chronic disease management such as diabetes, hypertension, and heart disease.